Am J Transplant, Volume 18, Suppl 3 Archives - Page 69 of 211 - ATC Abstracts

2018 American Transplant Congress
Variation in Post-Transplant Opiate Prescribing Patterns across Transplant Centers
A. Mathur, D. Ubl, J. Harbell, K. Croome, C. Taner, J. Heimbach, A. Moss, E. Habermann.
Mayo Clinic, Rochester, Phoenix, Jacksonville.
Background: Excess opiate prescribing has led to an epidemic, and evidence to guide abdominal transplant practice is lacking. We aimed to identify variation in opiate…
2018 American Transplant Congress
Humoral Immune Response to Seasonal Influenza Infection in Transplant Recipients
C. Hirzel,¹ V. Ferreira,¹ A. L'Huillier,¹ K. Hoschler,² E. Cordero,³ G. Reid,⁴ J. Englund,⁵ A. Limaye,⁶ A. Humar,¹ D. Kumar.¹
¹UHN, Toronto, Canada; ²Public Health England, London, United Kingdom; ³REIPI, Sevilla, Spain; ⁴LUMC, Chicago; ⁵SCH, Seattle; ⁶UOWMC, Seattle.
Background: Little is known about the serologic response to natural influenza infection in transplant recipients. We describe the hemagglutinin antibody response to influenza A/H1N1 infection…
2018 American Transplant Congress
Thrombotic Microangiopathy after Renal Transplantation: A Clinicopathological Study and Identification of Prognostic Factors
K. Dessaix,¹ C. Bontoux,² O. Aubert,¹ J. Zuber,¹ R. Sberro Soussan,¹ V. Frémeaux-Bacchi,³ M. Le Quintrec,⁴ C. Legendre,¹ M. Rabant.²
¹Renal Transplantation Department, Necker-Enfants Malades Hospital, Paris, France; ²Pathology Department, Necker-Enfants Malades Hospital, Paris, France; ³Immunology Laboratory, Georges Pompidou European Hospital, Paris, France; ⁴Nephrology Department, CHU Montpellier, Montpellier, France.
IntroductionThrombotic microangiopathy (TMA), whether de novo or recurrent, is a serious complication after renal transplantation, but prognostic factors and the role of complement inhibitors in…
2018 American Transplant Congress
Familial Risk of End-Stage Renal Disease in Healthy Live Kidney Donors
A. Muzaale,¹ A. Massie,¹ F. Al Ammary,¹ K. Lentine,² D. Segev.¹
¹Johns Hopkins University, Baltimore; ²Saint Louis University, St. Louis.
Kidney donor candidates are rigorously evaluated so that only the lowest risk are cleared for donation; however, it is not standard practice to exclude candidates…
2018 American Transplant Congress
Impact of the Differences between Body Mass Index of Recipient and Donor in a Population of Robotic Kidney Transplant
K. Tulla,¹ I. Tzvetanov,¹ C. Di Bella,¹ F. Gheza,¹ M. Spaggiari,¹ J. Oberholzer,² E. Benedetti.¹
¹Surgery, University of Illinois, Chicago, IL; ²Surgery, Universit of Virginia, Virginia, VA.
Introduction: The recent introduction of minimally invasive technique allows to perform kidney transplant in otherwise suitable recipients regardless the recipient BMI. This could lead to…
2018 American Transplant Congress
Should More Donation after Cardiac Death Livers Be Used in Pediatric Transplantation?
C. Hwang,¹ S. Levea,² M. MacConmara.¹
¹Surgery, UT Southwestern Medical Center, Dallas, TX; ²Medicine, UT Southwestern Medical Center, Dallas, TX.
Introduction: Multiple strategies exist to increase the organ pool for livers in pediatric recipients, including using split livers, high risk livers, and donation after cardiac…
2018 American Transplant Congress
Risk Factors for Chronic Opioid Use after Liver Transplantation
J. Fleming, D. Taber, B. O'Brien, N. Patel, N. Pilch, R. Gilbert, L. Wilson, Z. Elmaasarani, S. Ball, P. Mauldin, P. Baliga.
MUSC, Charleston, SC.
Opioid use is associated with increased readmissions and mortality in the liver transplant (OLTx) population. The aim of our study was to identify risk factors…
2018 American Transplant Congress
Identification of Anti-Inflammatory and Pro-Inflammatory Gut Microbiota That Determine Graft Survival
Y. Xiong, C. Brinkman, L. Hittle, W. Fricke, E. Mongodin, J. Bromberg.
UMB, MD.
Introduction: The gut microbiota induce and train the host immune system. Whether microbiota from contrasting environments of colitic or pregnant mice are pro- or anti-inflammatory…
2018 American Transplant Congress
IL-17 is Critical for Airway Epithelial Injury after Transplantation
R. Zhang,¹ H. Fang,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
¹Department of Immunology, Capital Medical University, Beijing, China; ²Department of Thoracic Surgery, Chaoyang Hospital, Beijing, China; ³Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Background: Obliterative bronchiolitis is the major obstacle limiting long-term allograft survival of lung transplantation. Airway epithelium is the primary target in obliterative airway diseases. Th17…
2018 American Transplant Congress
Estimated Impact of the Number of Simultaneous Offers on Kidney Delay and Discard
M. Mankowski,¹ S. Raghavan,³ C. Holscher,² M. Kosztowski,² D. Segev,² S. Gentry.⁴
¹King Abdullah University of Science and Technology, Thuwal, Saudi Arabia; ²Johns Hopkins University, Baltimore; ³University of Maryland, College Park; ⁴US Naval Academy, Annapolis.
Following local decline of a recovered kidney, making regional and national offers in larger simultaneous batches might decrease discards. We simulated varying batch sizes for…